PT - JOURNAL ARTICLE AU - Keskinocak, Pinar AU - Oruc, Buse Eylul AU - Baxter, Arden AU - Asplund, John AU - Serban, Nicoleta TI - The impact of social distancing on COVID19 spread: State of Georgia case study AID - 10.1101/2020.04.29.20084764 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.29.20084764 4099 - http://medrxiv.org/content/early/2020/09/18/2020.04.29.20084764.short 4100 - http://medrxiv.org/content/early/2020/09/18/2020.04.29.20084764.full AB - As the spread of COVID19 in the US continues to grow, local and state officials face difficult decisions about when and how to transition to a “new normal.” The goal of this study is to project the number of COVID19 infections and resulting severe outcomes, and the need for hospital capacity under social distancing, particularly, shelter-in-place and voluntary quarantine for the State of Georgia. We developed an agent-based simulation model to project the infection spread. The model utilizes COVID19-specific parameters and data from Georgia on population interactions and demographics. The simulation study covered a seven and a half-month period, testing different social distancing scenarios, including baselines (no-intervention or school closure only) and combinations of shelter-in-place and voluntary quarantine with different timelines and compliance levels. The following outcomes are compared at the state and community levels: the number and percentage of cumulative and daily new symptomatic and asymptomatic infections, hospitalizations, and deaths; COVID19-related demand for hospital beds, ICU beds, and ventilators. The results suggest that shelter-in-place followed by voluntary quarantine reduced peak infections from approximately 180K under no intervention and 113K under school closure, respectively, to below 53K, and delayed the peak from April to July or later. Increasing shelter-in-place duration from four to five weeks yielded 2-9% and 3-11% decrease in cumulative infection and deaths, respectively. Regardless of the shelter-in-place duration, increasing voluntary quarantine compliance decreased daily new infections from almost 53K to 25K, and decreased cumulative infections by about 50%. The cumulative number of deaths ranged from 6,660 to 19,430 under different scenarios. Peak infection date varied across scenarios and counties; on average, increasing shelter-in-place duration delayed the peak day by 6 days. Overall, shelter-in-place followed by voluntary quarantine substantially reduced COVID19 infections, healthcare resource needs, and severe outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research was supported in part by the William W. George (PK) and by the Virginia C. and Joseph C. Mello (NS) endowments and the following benefactors at Georgia Tech: Andrea Laliberte, Joseph C. Mello, Richard "Rick" E. & Charlene Zalesky, and Claudia & Paul Raines. This research was also supported in part by the National Science Foundation Graduate Research Fellowship DGE-1650044 (AB), by NSF grant MRI 1828187, and research cyberinfrastructure resources and services provided by the Partnership for an Advanced Computing Environment (PACE) at the Georgia Tech. The funders played no role in the study design, data collection, analysis, interpretation, or in writing the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study uses publicly available de-identified data thus does not require IRB approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe manuscript utilizes publicly available data sources and model parameters from the literature. All sources are cited in the manuscript. https://dph.georgia.gov/covid-19-daily-status-report http://data.census.gov http://data5.ctpp.transportation.org https://github.com/nytimes/covid-19-data